Financials
- Market Capitalization 142.16 M
- Employee 29
- Founded 2014
- CEO N/A
- Website www.cuebiopharma.com
- Headquarter Delaware, United States
- FIGI BBG00FVMPFN7
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.09
Rapporto prezzo/fatturato
1.07
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3684 | MOLN Molecular Partners AG - American Depositary Shares | 3.67 USD | -3.17% | -3.67% | -8.25% | -3.67% | 148.17 M USD | ||
| 3689 | CDXS Codexis, Inc. - Common Stock | 1.32 USD | -6.38% | -0.75% | -10.20% | -48.64% | 144.55 M USD | ||
| 3711 | IPHA Innate Pharma S.A. - American Depositary Shares | 1.47 USD | -0.68% | -3.92% | -20.54% | -30.66% | 137.77 M USD | ||
| 3713 | AVXL Anavex Life Sciences Corp. - Common Stock | 1.48 USD | -1.99% | -5.73% | -42.86% | -83.18% | 137.19 M USD |